These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11297535)

  • 1. Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus.
    Varrault A; Bilanges B; Mackay DJ; Basyuk E; Ahr B; Fernandez C; Robinson DO; Bockaert J; Journot L
    J Biol Chem; 2001 Jun; 276(22):18653-6. PubMed ID: 11297535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus.
    Mackay DJ; Coupe AM; Shield JP; Storr JN; Temple IK; Robinson DO
    Hum Genet; 2002 Feb; 110(2):139-44. PubMed ID: 11935319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.
    Kamiya M; Judson H; Okazaki Y; Kusakabe M; Muramatsu M; Takada S; Takagi N; Arima T; Wake N; Kamimura K; Satomura K; Hermann R; Bonthron DT; Hayashizaki Y
    Hum Mol Genet; 2000 Feb; 9(3):453-60. PubMed ID: 10655556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
    Valleley EM; Cordery SF; Bonthron DT
    Hum Mol Genet; 2007 Apr; 16(8):972-81. PubMed ID: 17341487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome.
    Arima T; Kamikihara T; Hayashida T; Kato K; Inoue T; Shirayoshi Y; Oshimura M; Soejima H; Mukai T; Wake N
    Nucleic Acids Res; 2005; 33(8):2650-60. PubMed ID: 15888726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A conserved imprinting control region at the HYMAI/ZAC domain is implicated in transient neonatal diabetes mellitus.
    Arima T; Drewell RA; Arney KL; Inoue J; Makita Y; Hata A; Oshimura M; Wake N; Surani MA
    Hum Mol Genet; 2001 Jul; 10(14):1475-83. PubMed ID: 11448939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer.
    Kamikihara T; Arima T; Kato K; Matsuda T; Kato H; Douchi T; Nagata Y; Nakao M; Wake N
    Int J Cancer; 2005 Jul; 115(5):690-700. PubMed ID: 15751035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
    Bilanges B; Varrault A; Basyuk E; Rodriguez C; Mazumdar A; Pantaloni C; Bockaert J; Theillet C; Spengler D; Journot L
    Oncogene; 1999 Jul; 18(27):3979-88. PubMed ID: 10435621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse Zac1 locus: basis for imprinting and comparison with human ZAC.
    Smith RJ; Arnaud P; Konfortova G; Dean WL; Beechey CV; Kelsey G
    Gene; 2002 Jun; 292(1-2):101-12. PubMed ID: 12119104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel imprinted gene, HYMAI, is located within an imprinted domain on human chromosome 6 containing ZAC.
    Arima T; Drewell RA; Oshimura M; Wake N; Surani MA
    Genomics; 2000 Aug; 67(3):248-55. PubMed ID: 10936046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer.
    Abdollahi A; Pisarcik D; Roberts D; Weinstein J; Cairns P; Hamilton TC
    J Biol Chem; 2003 Feb; 278(8):6041-9. PubMed ID: 12473647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines.
    Piras G; El Kharroubi A; Kozlov S; Escalante-Alcalde D; Hernandez L; Copeland NG; Gilbert DJ; Jenkins NA; Stewart CL
    Mol Cell Biol; 2000 May; 20(9):3308-15. PubMed ID: 10757814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
    Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
    Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.
    Bilanges B; Varrault A; Mazumdar A; Pantaloni C; Hoffmann A; Bockaert J; Spengler D; Journot L
    Oncogene; 2001 Mar; 20(10):1246-53. PubMed ID: 11313869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.
    Jarmalaite S; Laurinaviciene A; Tverkuviene J; Kalinauskaite N; Petroska D; Böhling T; Husgafvel-Pursiainen K
    Cancer Genet; 2011 Jul; 204(7):398-404. PubMed ID: 21872827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An imprinted locus associated with transient neonatal diabetes mellitus.
    Gardner RJ; Mackay DJ; Mungall AJ; Polychronakos C; Siebert R; Shield JP; Temple IK; Robinson DO
    Hum Mol Genet; 2000 Mar; 9(4):589-96. PubMed ID: 10699182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas.
    Pagotto U; Arzberger T; Theodoropoulou M; Grübler Y; Pantaloni C; Saeger W; Losa M; Journot L; Stalla GK; Spengler D
    Cancer Res; 2000 Dec; 60(24):6794-9. PubMed ID: 11156367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the role of common genetic variation in the transient neonatal diabetes mellitus (TNDM) region in type 2 diabetes: a comparative genomic and tagging single nucleotide polymorphism approach.
    Gloyn AL; Mackay DJ; Weedon MN; McCarthy MI; Walker M; Hitman G; Knight BA; Owen KR; Hattersley AT; Frayling TM
    Diabetes; 2006 Aug; 55(8):2272-6. PubMed ID: 16873690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisulphite sequencing of the transient neonatal diabetes mellitus DMR facilitates a novel diagnostic test but reveals no methylation anomalies in patients of unknown aetiology.
    Mackay DJ; Temple IK; Shield JP; Robinson DO
    Hum Genet; 2005 Mar; 116(4):255-61. PubMed ID: 15635480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.